Sinovac Biotech Ltd (SVA): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2010-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Older than the company's other figures. The latest EBITDA is for the year ended 2012-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

-$16.66M
Year ended 2012-12-31
$44.39M2009-12-31: $44.39M2010-12-31: -$9.12M2011-12-31: $8.20M2012-12-31: -$16.66M-$16.66M
2009-12-31 EBITDA (USD) 2012-12-31
Period endedEBITDAChange YoYSource filing
2012-12-31-$16.66Mn/m2015-04-29, From 2012-01-01
2011-12-31$8.20Mn/m2014-04-16, From 2011-01-01
2010-12-31-$9.12Mn/c2013-05-23, From 2010-01-01
2009-12-31$44.39Mn/a2012-04-12, From 2009-01-01